The Headache Inducing Effects of Cilostazol on Migraine Patients
NCT01841827 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14
Last updated 2014-06-06
Summary
We will use Cilostazol as a tool to investigate its headache inducing effects in migraine patients.
Conditions
Interventions
- DRUG
-
Cilostazol
- DRUG
Sponsors & Collaborators
-
Danish Headache Center
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-04-30
- Primary Completion
- 2013-06-30
- Completion
- 2013-06-30
Countries
- Denmark
Study Locations
More Related Trials
-
The Effect of Sumatriptan and Placebo on CGRP Induced Headache
NCT03542357 ·Status: COMPLETED ·Phase: NA
-
The Effect of Sumatriptan and Placebo on Isosorbide-5-mononitrate Induced Headache
NCT02485340 ·Status: COMPLETED ·Phase: NA
-
Ibudilast in the Treatment of Patients With Chronic Migraine.
NCT01389193 ·Status: COMPLETED ·Phase: PHASE1
-
PACAP-38 Infusion in Patients With Cluster Headache
NCT03814226 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine Patients
NCT04452929 ·Status: UNKNOWN ·Phase: NA
-
Induction of Migraine Attacks With Aura Using Calcitonin Gene-Related Peptide
NCT07021859 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of Intranasal Ketorolac for the Acute Treatment of Migraine
NCT00483717 ·Status: COMPLETED ·Phase: PHASE2
-
Carbachols Headache-inducing Effect and Changes in Cerebral Blood Flow in Migraine Patients
NCT00564408 ·Status: COMPLETED ·Phase: NA
-
Staccato Prochlorperazine in Migraine (in Clinic)
NCT00610428 ·Status: COMPLETED ·Phase: PHASE2
-
Dose-ranging Study of Oral COL-144 in Acute Migraine Treatment
NCT00883051 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Expectation and Knowledge on Rizatriptan and Placebo Treatment of Acute Migraine Headache
NCT00719134 ·Status: COMPLETED ·Phase: PHASE4
-
Prophylactic Treatment of Episodic Cluster Headache
NCT00184587 ·Status: COMPLETED ·Phase: PHASE2
-
Dose Ranging Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache
NCT00534560 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Prophylactic Efficacy of tDCS in Chronic Migraine
NCT02120326 ·Status: COMPLETED ·Phase: NA
-
Lasmiditan Compared to Placebo in the Acute Treatment of Migraine in Korean
NCT04218162 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Tolerability, and Safety Study of DFN-15
NCT03006276 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Test an Approved Product in the Early Treatment of Migraine (0462-066)
NCT00095004 ·Status: COMPLETED ·Phase: PHASE3
-
Migraine Inducing Effects and Changes in Brain Haemodynamics of PGI2
NCT00510172 ·Status: UNKNOWN ·Phase: NA
-
Ibudilast in the Treatment of Medication Overuse Headache
NCT01317992 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
CGRP's Cluster Headache Inducing Abilities in Cluster Headache Patients
NCT02466334 ·Status: COMPLETED ·Phase: NA
-
Headache Inducing Effect of Cromakalim in Migraine Patients
NCT03228355 ·Status: COMPLETED ·Phase: NA
-
The Efficacy and Safety of Intra-oral Topical Ketoprofen for the Treatment of Acute Migraine
NCT01228552 ·Status: UNKNOWN ·Phase: PHASE3
-
Clinical Characteristics and Pathophysiology of Post-Traumatic Headache
NCT03791515 ·Status: COMPLETED ·Phase: NA
-
Comparison of Ketorolac Nasal Spray to Sumatriptan Nasal Spray and Placebo for Acute Treatment of Migraine
NCT01807234 ·Status: COMPLETED ·Phase: PHASE4
-
A Retrospective Chart Review to Evaluate Diagnosis and Treatment of Chronic Migraine and Headache
NCT01946126 ·Status: COMPLETED